Warning: Undefined array key "Sample_ID" in /data/html/Aging-ReG/public/browse_detail_2.php on line 219

Warning: Undefined array key "Experimental_model_species_W" in /data/html/Aging-ReG/public/browse_detail_2.php on line 240

Warning: Trying to access array offset on null in /data/html/Aging-ReG/public/browse_detail_2.php on line 248

Warning: Trying to access array offset on null in /data/html/Aging-ReG/public/browse_detail_2.php on line 255

Aging Overview

External factors

External factors: Bufalin
Aging type: Accelerate
Aging characteristic:
Category: Chemical compounds
Phenotype: Prostate cancer
Experimental category: HL
Tissue type: --
Cell name: LNCaP
PMID: 30166403
Experiment: Flow cytometry//SA-β-gal activity assay//Cell morphological analysis
Description: Cell cycle distribution analyses showed increased sub G0/1 apoptotic fraction at bufalin exposure of 20 nM.We examined cellular senescence phenotype in bufalin-exposed LNCaP (PTEN-negative, high AKT activity) cells by evaluating SA-β-gal activity as a cytochemical marker and observed increased proportion of cells with blue staining and flattened morphology.



Warning: Undefined variable $target_genes in /data/html/Aging-ReG/public/browse_detail_2.php on line 385

Regulatory relationship

Regulatory pathway: p53-p21
R-EF-Pathway: Upregulation
Official symbol(s):
Warning: Undefined variable $name_all in /data/html/Aging-ReG/public/browse_detail_2.php on line 525
TP53-CDKN1A
Pathway experiment: Western blot
Pathway description: Bufalin treatment for 48 h led to an increased total P53 protein abundance at 10-20 nM as well as that of P21CIP1 in a concentration-dependent manner.


Aging network

Annotation:

The green line represents Upregulation.

The purple line represents Downregulation.

The orange line represents Activation.

The yellow line represents Inhibition.

The gray line represents Unclear.



Pathway view